TY - JOUR
TI - Use of triiodothyronine to treat critically ill COVID-19 patients: A new clinical trial
AU - Pantos, C.
AU - Tseti, I.
AU - Mourouzis, I.
JO - Critical Care and Resuscitation
PY - 2020
VL - 24
TODO - 1
SP - null
PB - BioMed Central Ltd.
SN - null
TODO - 10.1186/s13054-020-02934-2
TODO - liothyronine;  mitogen activated protein kinase p38;  thyroid hormone;  liothyronine;  thyroid hormone receptor alpha, cell damage;  coronavirus disease 2019;  critically ill patient;  drug use;  human;  Letter;  mortality;  natural killer cell;  priority journal;  septic shock;  virus entry;  virus load;  virus replication;  Betacoronavirus;  Coronavirus infection;  critical illness;  pandemic;  virus pneumonia, Betacoronavirus;  Coronavirus Infections;  Critical Illness;  Humans;  Pandemics;  Pneumonia, Viral;  Thyroid Hormone Receptors alpha;  Triiodothyronine
TODO - null
ER -